Côté HC - Search Results

1

Mitochondrial toxicity in the era of HAART: evaluating venous lactate and peripheral blood mitochondrial DNA in HIV-infected patients taking antiretroviral therapy.

Montaner JS, Côté HC, Harris M, Hogg RS, Yip B, Chan JW, Harrigan PR, O'Shaughnessy MV. Montaner JS, et al. Among authors: cote hc. J Acquir Immune Defic Syndr. 2003 Sep;34 Suppl 1:S85-90. doi: 10.1097/00126334-200309011-00013. J Acquir Immune Defic Syndr. 2003. PMID: 14562863 Review.

2

Age at Natural Menopause in Women Living with HIV: A Cross-Sectional Study Comparing Self-Reported and Biochemical Data.

Swann SA, King EM, Tognazzini S, Campbell AR, Levy SLA, Pick N, Prior JC, Elwood C, Loutfy M, Nicholson V, Kaida A, Côté HCF, Murray MCM. Swann SA, et al. Viruses. 2023 Apr 26;15(5):1058. doi: 10.3390/v15051058. Viruses. 2023. PMID: 37243146 Free PMC article.

3

Clinical utility of testing human immunodeficiency virus for drug resistance.

Harrigan PR, Côté HC. Harrigan PR, et al. Among authors: cote hc. Clin Infect Dis. 2000 Jun;30 Suppl 2:S117-22. doi: 10.1086/313861. Clin Infect Dis. 2000. PMID: 10860895 Review.

4

Human immunodeficiency virus type 1 protease cleavage site mutations associated with protease inhibitor cross-resistance selected by indinavir, ritonavir, and/or saquinavir.

Côté HC, Brumme ZL, Harrigan PR. Côté HC, et al. J Virol. 2001 Jan;75(2):589-94. doi: 10.1128/JVI.75.2.589-594.2001. J Virol. 2001. PMID: 11134271 Free PMC article.

5

Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patients.

Côté HC, Brumme ZL, Craib KJ, Alexander CS, Wynhoven B, Ting L, Wong H, Harris M, Harrigan PR, O'Shaughnessy MV, Montaner JS. Côté HC, et al. N Engl J Med. 2002 Mar 14;346(11):811-20. doi: 10.1056/NEJMoa012035. N Engl J Med. 2002. PMID: 11893792 Free article.

6

Assessment of precision and concordance of quantitative mitochondrial DNA assays: a collaborative international quality assurance study.

Hammond EL, Sayer D, Nolan D, Walker UA, Ronde Ad, Montaner JS, Cote HC, Gahan ME, Cherry CL, Wesselingh SL, Reiss P, Mallal S. Hammond EL, et al. Among authors: cote hc. J Clin Virol. 2003 May;27(1):97-110. doi: 10.1016/s1386-6532(02)00134-8. J Clin Virol. 2003. PMID: 12727535

7

Mitochondrial:nuclear DNA ratios in peripheral blood cells from human immunodeficiency virus (HIV)-infected patients who received selected HIV antiretroviral drug regimens.

Côté HC, Yip B, Asselin JJ, Chan JW, Hogg RS, Harrigan PR, O'Shaughnessy MV, Montaner JS. Côté HC, et al. J Infect Dis. 2003 Jun 15;187(12):1972-6. doi: 10.1086/375353. Epub 2003 May 29. J Infect Dis. 2003. PMID: 12792876

8

Insulin-like growth factor-1 protects ischemic murine myocardium from ischemia/reperfusion associated injury.

Davani EY, Brumme Z, Singhera GK, Côté HC, Harrigan PR, Dorscheid DR. Davani EY, et al. Among authors: cote hc. Crit Care. 2003 Dec;7(6):R176-83. doi: 10.1186/cc2375. Epub 2003 Oct 10. Crit Care. 2003. PMID: 14624693 Free PMC article.

9

Montaner JS, Côté HC, Harris M, Hogg RS, Yip B, Harrigan PR, O'Shaughnessy MV. Montaner JS, et al. Among authors: cote hc. Clin Infect Dis. 2004 Mar 1;38 Suppl 2:S73-9. doi: 10.1086/381449. Clin Infect Dis. 2004. PMID: 14986278

10

Lopinavir/ritonavir plus nevirapine as a nucleoside-sparing approach in antiretroviral-experienced patients (NEKA study).

Negredo E, Moltó J, Burger D, Côté H, Miró O, Ribalta J, Martínez E, Puig J, Ruiz L, Salazar J, López S, Montaner J, Rey-Joly C, Clotet B. Negredo E, et al. J Acquir Immune Defic Syndr. 2005 Jan 1;38(1):47-52. doi: 10.1097/00126334-200501010-00009. J Acquir Immune Defic Syndr. 2005. PMID: 15608524 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

131 results

Search Page

Filters